| Filed On | Filing |
|---|---|
| 10 Apr 2026 |
Form 3: Herman Gary L, Director
No securities owned |
| 09 Apr 2026 |
Form 3: Sherb Eric Michael, Director
No securities owned |
| 02 Apr 2026 |
Form 3: Velez Marlene, Director
No securities owned |
| 24 Oct 2025 |
Form 3: Doss Howard A., Director
No securities owned |
| 21 Oct 2025 |
Form 3: Fell Donald G., Director
No securities owned |
| 14 Oct 2025 |
Form 3: Lee Steven Dale, Director
No securities owned |
| 08 Jul 2025 |
Form 3: Peterson Michael L, Director
No securities owned |
| 24 Apr 2025 |
Form 3: Kalla Srinivas, Chief Information Officer
Holds 293,333 shares of Common Stock, par value $0.0001 |
| 23 Apr 2025 |
Form 3: DiSiena Mark, Chief Financial Officer
No securities owned |
| 21 Mar 2025 |
Form 3: Patel Prashant, Director
Holds 2,236,000 shares of Common Stock, par value $0.0001 |
| 14 Mar 2025 |
Form 3: Panchal Nikul, Chief Pharmacy Officer
Holds 285,761 shares of Common Stock, par value $0.0001 |
| 12 Mar 2025 |
Form 3: Norton Brian, Chief Executive Officer
Holds 44,720 shares of Common Stock, par value $0.0001 |
| 28 Feb 2025 |
Form 3: Syed Sajid, Director
Holds 44,720 shares of Common Stock, par value $0.0001 |
| 28 Feb 2025 |
Form 3: Pirani Shafaat, Chief Clinical Officer
Holds 67,080 shares of Common Stock, par value $0.0001 |
| 28 Feb 2025 |
Form 3: Shanahan Rebecca M, Director
Holds 44,720 shares of Common Stock, par value $0.0001 |
| 24 Feb 2025 |
Form 3: Ajjarapu Surendra K, Director
Holds 3,863,200 shares of Common Stock, par value $0.0001 |
| 24 Feb 2025 |
Form 3: Anderson Donald William, Director
Holds 44,720 shares of Common Stock, par value $0.0001 |
Loading...
